Summary of cutting-edge companies related to MIT fighting the new coronavirus at the forefront
The talent generated by the Massachusetts Institute of Technology (MIT), one of the elite prestigious schools in the United States, has been active in a wide range of fields such as biotechnology, mobile technology, data analysis, and
MIT-affiliated companies take on Covid-19 | MIT News
http://news.mit.edu/2020/mit-companies-covid-19-0326
◆ Moderna Therapeutics
Moderna Therapeutics is a biotechnology company based in Cambridge, Mass. Professor Robert Langer , a professor in the Department of Chemical and Biological Engineering at MIT and a faculty member of the Institute of Medical Engineering Sciences (IMES) at MIT, was deeply involved in launching the business.
Such Modnana Therapeutics is a vaccine that can be expected to prevent new coronavirus infection in cooperation with the National Institutes of Health just two days after the Chinese authorities released the gene sequence of the new coronavirus on January 11, 2020 Has been successfully designed.
For more information on vaccines developed by Moderna Therapeutics and their clinical trials, read the following articles:
Looking for healthy volunteers for clinical trial of world's first new coronavirus vaccine-gigazine
The world's first human clinical trial of the new coronavirus vaccine starts-gigazine
The first trial of a vaccine developed by Moderna Therapeutics is expected to take about six weeks, and will further investigate its safety and immune implications. According to Moderna Therapeutics, it will take 12 to 18 months for the vaccine to become commercially available, but some people may be given the vaccine more quickly in an emergency.
◆ Alnylam Pharmaceuticals
Cambridge, Mass. Is also home to Alnylam Pharmaceuticals, a biotechnology company that uses RNA interference to develop therapeutics. The company announced on March 5 that it will partner with Vir Biotechnology, a company specializing in the treatment of infectious diseases, to begin developing new therapies for new coronavirus infections.
Alnylam Pharmaceuticals includes MIT's biology professor Philip Sharp and biology professor David Barthel , biophysical chemist Paul Siemel , who once taught at MIT, and Thomas, a postdoctoral fellow at MIT. Tashuru and Mr. Philip Mall is a company that was founded by et al.
Alnylam Pharmaceuticals plans to use its RNA interference technology in the lungs to identify potential therapeutics in the future. Mr. Sharp said about this initiative, `` Even if this partnership does not lead to the development of a new coronavirus infection treatment, there is great potential to help infectious disease victims in the future '' Was.
◆ Dimagi
Dimagi is also supporting the expansion of the new coronavirus infection, including the establishment of an information platform to respond to the new coronavirus in local governments including Nigeria's Ogun State .
The entrepreneur Jonathan Jackson founded Dimagi. While at MIT, Jackson met Vikram Kumar , who studied medicine at the Harvard-MIT Joint School of Medical Science and Technology , founded jointly by MIT and Harvard University, and co-founded Dimagi.
Jackson said that Dimagi is developing services in Nigeria and elsewhere, saying, `` Medical institutions operating at the forefront of new coronavirus infections can download new coronavirus-related apps for free and use them quickly. It ’s like an app store. ”
by Dimagi
◆ Biobot Analytics
Biobot Analytics , which addresses public health issues through sewage analysis, is a startup founded by Mariana Mathus, who studied epidemiology at MIT, in collaboration with Newsha Ghaeli, an urban science expert. Biobot Analytics can obtain a wide range of information from sewage samples, such as drugs, environmental pollutants, and antibiotics. By utilizing this know-how, the company has developed a method for investigating the spread of new coronaviruses.
The research method uses reverse transcription-polymerase chain reaction to detect traces of new coronavirus in sewage from medical institutions across the United States. As a result, the 'complement the infection inspection to individuals of the new coronavirus, it is possible to capture the signs of measurement and re-occurrence of the effects of the spread of infection measures at an early stage', the company announced it has been.
◆ Soofa
Soofa has developed a street bulletin board system that displays official information on the new coronavirus in cities in Massachusetts, such as Brookline and Somerville , taking advantage of the strength of being able to quickly and flexibly distribute information to urban spaces.
by
◆ Pathr
Pathr is an IT company that analyzes the movement of people in commercial facilities and the like by analyzing data using machine learning. CEO George Shaw, who earned a Masters of Science degree at MIT, said that while the San Francisco Bay Area where the company is based was partially blocked due to indoor evacuation orders , the spread of the new coronavirus infection was SocialDistance.ai for simulation has been developed.
Outbreak simulation results by SocialDistance.ai are as follows.
Outbreak-YouTube
If no countermeasures are taken and a new coronavirus holder appears in orange, ...
Transmission spreads in a chain.
Ultimately, nearly 40% of visitors were infected in a simulation of about 40 seconds.
On the other hand, this is the result of a simulation that keeps the social distance.
Even if the holder moves, the infection does not spread easily.
In the end, the infection has spread to some extent, but still only about 30% of visitors are infected. From this, it can be visually understood that even if the “
Shaw and his colleagues have already contacted managers of various public spaces, such as shopping malls, casinos, and retail stores, to provide information to help them decide whether to allow public spaces. It is going.
Related Posts:
